p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A

Abstract

Dysregulation of lipid metabolism is common in breast cancer. However, the underlying mechanisms remain elusive and the contribution of aberrant lipid metabolism to the malignant phenotypes of breast cancer is poorly understood. Here, we show that the nuclear protein p54(nrb)/Nono is highly expressed in breast cancer tissues as compared with the adjacent normal tissues in human patients. To determine the functions of p54(nrb) in breast cancer, we performed a biochemical screen and identified SREBP-1a, a master activator for genes involved in lipid biosynthesis, as a novel interacting protein of p54(nrb). In human breast cancer tissues, the levels of p54(nrb) and SREBP-1a proteins were positively correlated with each other. Our biochemical analyses showed that the conserved Y267 residue of p54(nrb) was required for its binding to the nuclear form of SREBP-1a. Interestingly, p54(nrb) binding to nuclear SREBP-1a caused an increase of nuclear SREBP-1a protein stability. As a result, p54(nrb) stimulates SREBP-1-meidated transcription of lipogenic genes and lipid production in breast cancer cells. Moreover, both p54(nrb) and SREBP-1a were required for breast cancer cell growth in vitro, and p54(nrb) binding to nuclear SREBP-1a was also critical for breast tumor development in vivo. Together, we conclude that p54(nrb) is a novel regulator of SREBP-1a in the nucleus, and our data suggest that p54(nrb) regulation of SREBP-1a supports the increased cellular demand of lipids for breast cancer growth. Thus, the SREBP pathway may represent a novel target for treating breast cancer.

Role of hepatoma‐derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma

“…Targeting lipid metabolism and its related regulators have emerged as a promising antitumor strategy. We have previously found that SREBP1‐mediated de novo lipogenesis promotes cancer cell proliferation by providing sufficient lipids (Liu et al ., 2016; Zhu et al ., 2016). Transcription factors require cofactors to help fully activate gene transcription.…”

Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO–TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum

“…10,42,43 Because it is involved in a variety of biological processes, including RNA splicing and editing, DNA unwinding and repairing, gene transcription and differentiation of stem cells, NONO(p54 nrb ) has been believed to play an important role in cancer. 42 In fact, p54 nrb has been found to be expressed strongly in prostate cancer 44 and malignant melanoma. 45 The specific features of NONO(p54 nrb ) in these distinctive neoplasms remain poorly understood because of their extreme rarity.…”

Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells

“…SREBP1 has an important role in cancer progression likely by providing the membrane building materials to support the rapid proliferation of cancer cells [16, 17]. We have utilized several experimental approaches to identify novel SREBP interacting proteins [18, 19]. Here, we presented a novel interaction between the nuclear protein MARVELD1 and the nuclear form of SREBP1.…”